AHZ will it keep moving forward, page-35

abdm (the red heart man) called it to 21c and i have called it to 21c but its gone the other way, it should be at 21c right now, if it was at 18.5c with only 20% of these sales and results back in Feb then it looks like the Pattersons lower initial income call whilst keeping their 23c TP incorrectly gained belief on market last few weeks.

For mine, AHZ has nothing to do with the general market which shows just how misunderstood biotech and how naive OZ investors are with biotech,

its a micro play not a macro play ...its got nothing to do with GDP, US or Euro growth stories, the exact opposite, the more viruses, the more heart attacks, the worse the human condition, the worse the recession, the more compulsion sales growth there will be and in a growing macro global economy it then gets the market pundits who invest on macro factors in as well as they think when people feel wealthier they will buy shares and go for that heart surgery or viral treatment maybe more so as an elective option. foolish totally...

The market SP at 12.5c (same SP as in May and July) gives a nil $0 NPV for the Coridon shares increase to 66%, 0 for the malaga factory, its redevlepment, 0 for booming Euro and US centre uptake at 11% pmnth, 0 for Canada approval, Singapore/Aust approval applications, 0 for HSV Ph1 final results nor the initiation of HPV/HSV trials shortly.

Its mindboggling on what shortsighted parameters traders value AHZ at.

AHZ is a bellweather in any condition, the sell off 16c to 12c is ridiculous.. total misreading of AHZ, biotech and the medical sales industry. As November hits now, bull run globally will make the macro investors buy in but the micro investors and analysts love this stock and keep talking it up and control this stock and its top20 .. its only a matter of time for it to make that move to 23c and then to 61c that Baillieu Holst assessed and upgraded recently. I think global investors will soon move on AHZ undervaluation in the OZ market